Press Releases
-
Miracell Demonstrates Cognition Impairment and Brain Function Improvement in Severe Alzheimer’s Patients Using ‘SMART M-CELL’-Based CD34+ Cell-Rich Autologous Blood Concentrate Therapy
-
SMART M-CELL technology gains FDA 510(k) clearance for U.S. market expansion
-
Stem cell platform shows promise in degenerative brain disease research
-
Miracell's SMART M-CELL Stem Cell Therapy Shows Cognitive Improvement in Severe Alzheimer's Patients
-
Regenerative medicine market sees breakthrough innovation from Korean biotech
-
Clinical study published in Molecular Neurobiology validates SMART M-CELL platform